InvestorsHub Logo
Followers 57
Posts 5722
Boards Moderated 0
Alias Born 12/13/2004

Re: volgoat post# 7341

Friday, 07/14/2006 7:24:59 PM

Friday, July 14, 2006 7:24:59 PM

Post# of 346866
Good results with mono...but preclinical showed better results with multi-dosing and even better results multi-dosing with combination therapy in both cancer and virus applications. And the second generation Mab could be even better than the chimeric. There is a lot of news yet to come!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News